Volpé R
Department of Medicine, University of Toronto, Ontario, Canada.
Crit Rev Clin Lab Sci. 1997;34(5):405-38. doi: 10.3109/10408369709006421.
In this era of cost containment, it is necessary to efficiently select the most important laboratory investigations for diagnostic and management purposes, with patient benefit as the ultimate objective. Thyroid function tests collectively represent a very costly item for laboratory services and have tended to be unselectively overutilized virtually until the present. Tests available for thyroid function testing include both in vitro and in vivo tests. Virtually all physicians are familiar with the free thyroxine (fT4) or its equivalents (fT4E), total and free triiodothyronine (TT3 and fT3), and sensitive thyrotrophin (TSH) assays, to which may be added plasma thyroglobulin (Tg), and thyroid autoantibodies (TAb) (including thyroid stimulating antibody [TSAb]). In vitro tests include thyroidal uptakes and scans, as well as other imaging techniques (e.g., ultrasound). Other less commonly used or obsolete techniques are not discussed. For screening or case finding where there is little probability that the patient(s) has thyroid dysfunction, a sensitive TSH assay is all that is initially required. If, however, the TSH result is elevated, a fT4E and TAb should then be performed. If the TSH is subnormal, then a fT4E, TT3, and (if still necessary) TSH response to TRH would determine if that patient was truly hyperthyroid (in elderly patients, a low TSH is often not associated with hyperthyroidism!). Conversely, not all patients with elevated fT4 are truly hyperthyroid. Uptakes and scans are primarily of importance in the correct diagnosis of unusual cases of hyperthyroidism and for nodular disease. When patients already diagnosed are being followed, proper selection of testing is again important, sometimes emphasizing one test over others (e.g., TT3); for example, in patients with Graves' Disease on anti-thyroid drugs, the fT4E and TSH values may not reflect the true status of the patient. On the one hand, the TSH may remain low for months after the patient has become euthyroid, and on the other hand, the fT4E may drop even below normal, whereas the T3 remains elevated (and the patient still hyperthyroid). The many other vagaries of these tests are also mentioned.
在这个成本控制的时代,有必要为了诊断和管理目的高效地选择最重要的实验室检查项目,最终目标是使患者受益。甲状腺功能检查总体上是实验室服务中一项成本很高的项目,直到现在实际上一直存在未加选择地过度使用的情况。可用于甲状腺功能检测的检查包括体外检查和体内检查。几乎所有医生都熟悉游离甲状腺素(fT4)或其等效物(fT4E)、总三碘甲状腺原氨酸和游离三碘甲状腺原氨酸(TT3和fT3)以及敏感促甲状腺激素(TSH)检测,还可能会增加血浆甲状腺球蛋白(Tg)和甲状腺自身抗体(TAb)(包括促甲状腺素抗体[TSAb])检测。体外检查包括甲状腺摄取和扫描,以及其他成像技术(如超声)。其他不太常用或已过时的技术在此不作讨论。对于筛查或病例发现,即患者患甲状腺功能障碍可能性很小的情况,最初仅需进行敏感的TSH检测。然而,如果TSH结果升高,那么就应进行fT4E和TAb检测。如果TSH低于正常,那么fT4E、TT3以及(如有必要)TSH对促甲状腺激素释放激素(TRH)的反应将确定该患者是否真的患有甲状腺功能亢进(在老年患者中,低TSH通常与甲状腺功能亢进无关!)。相反,并非所有fT4升高的患者都真的患有甲状腺功能亢进。摄取和扫描对于正确诊断不寻常的甲状腺功能亢进病例以及结节性疾病至关重要。当对已确诊的患者进行随访时,正确选择检测项目同样重要,有时会更强调某一项检测(如TT3);例如,对于服用抗甲状腺药物的格雷夫斯病患者,fT4E和TSH值可能无法反映患者的真实状况。一方面,患者甲状腺功能恢复正常后,TSH可能会持续数月保持较低水平,另一方面,fT4E可能会降至甚至低于正常水平,而T3仍会升高(且患者仍患有甲状腺功能亢进)。文中还提到了这些检测的许多其他变化无常的情况。